Taken together, our findings suggest that plasma PEDF may reflect a compensatory response to glomerular injury in patients with T2DM and thereby predicts the progression in UAE and subsequent deterioration in GFR. This evidence concerns the gene SERPINF1 and type 2 diabetes mellitus.